Our Molecular Genetics Suppliers

Our Molecular Genetics portfolio provides solutions for all areas of disease, including screening, diagnosis, and monitoring. Through a range of partners, Abacus dx aims to provide Australian and New Zealand laboratories with simple and efficient testing solutions for a range of methods including polymerase chain reaction, next-generation sequencing, and fluorescence in situ hybridisation.

Recent Blog Posts

Molecular
Asuragen – QuantideX ESR1 exoMutation Kit*

ESR1 Mutations are the Leading Cause of Primary Treatment Resistance in HR+ mBC
ESR1 gene codes for estrogen receptor alpha (ERα), and mutations in its ligand-binding domain trigger constant activation of the receptor, leading to excessive downstream signalling.

Read More »
Molecular
Biocartis – Idylla POLE-POLD1 Mutation Assay

The Idylla™ POLE-POLD1 Mutation Assay (RUO)* provides a rapid and reliable solution to close an important gap in oncology research by enabling molecular classification of endometrial cancer samples. Its fully automated solution is capable to detect 99% of […]

Read More »
Molecular
Biocartis – Idylla ThyroidPrint Assay

Idylla™ ThyroidPrint® Assay (RUO)* is a novel RT qPCR-based molecular signature that assesses a gene expression profile. Using a proprietary algorithm, ThyroidPrint provides assessment of indeterminate thyroid nodule cytology, classifying as low or high risk of malignancy.

[…]

Read More »
Molecular
Asuragen – AmplideX Nanopore Carrier Plus

Introducing the Asuragen AmplideX® Nanopore Carrier Plus Kit* – a revolutionary solution for carrier screening for challenging hard-to-read genes, leveraging long-read sequencing technology to provide unparalleled insights into genetic conditions. Expanded prenatal screening protocols traditionally require multiple methods to […]

Read More »
Top
Abacus dx